Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.

Clinical lymphoma, myeloma & leukemia - 1 Sept 2018

Lee Yen-Chien, Hsieh Chung-Cheng, Lee Yen-Ling, Li Chung-Yi

Abstract excerpt

Molecular markers are important in guiding treatment and predicting outcome in the genomic era. Meta-analysis of molecular markers in myelofibrosis through a search of PubMed and Medline through October 31, 2017 was performed. Markers with more than 3 studies that compared overall survival (OS) and leukemia-free survival (LFS) were analyzed. A total of 16 studies were included. Hazard ratios (HRs) for OS were as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to ASXL1 gene
Share to CALR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to SRSF2 gene

Share to Genomics

Share to Mutation

Share to Primary Myelofibrosis

Share to Prognosis

Source

Identifiers

PMID: 29970342
DOI: 10.1016/j.clml.2018.06.004

Genes

SRSF2
JAK2
ASXL1
CALR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.PMID 29970342Read ↗

Prognostication in MF: from CBC to cytogenetics to molecular markers.Semantic proximity Read ↗

Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

Prognosis of Primary Myelofibrosis in the Genomic Era.Semantic proximity Read ↗

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patientsSemantic proximity Read ↗

[Recent advances of molecular mechanisms influencing prognosis of myelodysplastic syndrome - review].Semantic proximity Read ↗

Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information.Semantic proximity Read ↗

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read ↗

Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.Semantic proximity Read ↗

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.Semantic proximity Read ↗

Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.Semantic proximity Read ↗

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis.Semantic proximity Read ↗

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.